193 related articles for article (PubMed ID: 27595835)
1. Prognostic aspects of dynamic contrast-enhanced magnetic resonance imaging in synchronous distant metastatic rectal cancer.
Yu J; Xu Q; Huang DY; Song JC; Li Y; Xu LL; Shi HB
Eur Radiol; 2017 May; 27(5):1840-1847. PubMed ID: 27595835
[TBL] [Abstract][Full Text] [Related]
2. Role of dynamic contrast-enhanced MRI in predicting severe acute radiation-induced rectal injury in patients with rectal cancer.
Chen Y; Ding L; Zhang ZW; Wu XH; Que YT; Ma YR; Liu YY; Wen ZQ; Yang XY; Lu BL; Bao Y; Niu SQ; Yu SP
Eur Radiol; 2024 Mar; 34(3):1471-1480. PubMed ID: 37665390
[TBL] [Abstract][Full Text] [Related]
3. Limited accuracy of DCE-MRI in identification of pathological complete responders after chemoradiotherapy treatment for rectal cancer.
Gollub MJ; Tong T; Weiser M; Zheng J; Gonen M; Zakian KL
Eur Radiol; 2017 Apr; 27(4):1605-1612. PubMed ID: 27436029
[TBL] [Abstract][Full Text] [Related]
4. Correlation between quantitative and semiquantitative parameters in DCE-MRI with a blood pool agent in rectal cancer: can semiquantitative parameters be used as a surrogate for quantitative parameters?
Dijkhoff RAP; Maas M; Martens MH; Papanikolaou N; Lambregts DMJ; Beets GL; Beets-Tan RGH
Abdom Radiol (NY); 2017 May; 42(5):1342-1349. PubMed ID: 28050622
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Diagnostic Performance between Perfusion-Related Intravoxel Incoherent Motion DWI and Dynamic Contrast-Enhanced MRI in Rectal Cancer.
Li M; Xu X; Xia K; Jiang H; Jiang J; Sun J; Lu Z
Comput Math Methods Med; 2021; 2021():5095940. PubMed ID: 34367318
[TBL] [Abstract][Full Text] [Related]
6. Pretreatment magnetic resonance imaging of regional lymph nodes with carcinoembryonic antigen in prediction of synchronous distant metastasis in patients with rectal cancer.
Liu H; Cui Y; Shen W; Fan X; Cui L; Zhang C; Ren G; Fu J; Wang D
Oncotarget; 2016 May; 7(19):27199-207. PubMed ID: 27070083
[TBL] [Abstract][Full Text] [Related]
7. Association between high-resolution MRI-detected extramural vascular invasion and tumour microcirculation estimated by dynamic contrast-enhanced MRI in rectal cancer: preliminary results.
Chen Y; Yang X; Wen Z; Liu Y; Lu B; Yu S; Xiao X
BMC Cancer; 2019 May; 19(1):498. PubMed ID: 31133005
[TBL] [Abstract][Full Text] [Related]
8. Dynamic contrast-enhanced MR imaging pharmacokinetic parameters as predictors of treatment response of brain metastases in patients with lung cancer.
Kuchcinski G; Le Rhun E; Cortot AB; Drumez E; Duhal R; Lalisse M; Dumont J; Lopes R; Pruvo JP; Leclerc X; Delmaire C
Eur Radiol; 2017 Sep; 27(9):3733-3743. PubMed ID: 28210799
[TBL] [Abstract][Full Text] [Related]
9. Quantitating whole lesion tumor biology in rectal cancer MRI: taking a lesson from FDG-PET tumor metrics.
Gollub MJ; Hotker AM; Woo KM; Mazaheri Y; Gonen M
Abdom Radiol (NY); 2018 Jul; 43(7):1575-1582. PubMed ID: 29159523
[TBL] [Abstract][Full Text] [Related]
10. Dynamic multi-echo DCE- and DSC-MRI in rectal cancer: Low primary tumor K
Grøvik E; Redalen KR; Storås TH; Negård A; Holmedal SH; Ree AH; Meltzer S; Bjørnerud A; Gjesdal KI
J Magn Reson Imaging; 2017 Jul; 46(1):194-206. PubMed ID: 28001320
[TBL] [Abstract][Full Text] [Related]
11. Quantitative free-breathing dynamic contrast-enhanced MRI in hepatocellular carcinoma using gadoxetic acid: correlations with Ki67 proliferation status, histological grades, and microvascular density.
Chen J; Chen C; Xia C; Huang Z; Zuo P; Stemmer A; Song B
Abdom Radiol (NY); 2018 Jun; 43(6):1393-1403. PubMed ID: 28939963
[TBL] [Abstract][Full Text] [Related]
12. Differentiation of Hemangioblastoma from Metastatic Brain Tumor using Dynamic Contrast-enhanced MR Imaging.
Cha J; Kim ST; Nam DH; Kong DS; Kim HJ; Kim YK; Kim HY; Park GM; Jeon P; Kim KH; Byun HS
Clin Neuroradiol; 2017 Sep; 27(3):329-334. PubMed ID: 26952018
[TBL] [Abstract][Full Text] [Related]
13. MRI-detected extramural vascular invasion is an independent prognostic factor for synchronous metastasis in patients with rectal cancer.
Sohn B; Lim JS; Kim H; Myoung S; Choi J; Kim NK; Kim MJ
Eur Radiol; 2015 May; 25(5):1347-55. PubMed ID: 25500963
[TBL] [Abstract][Full Text] [Related]
14. Multiparametric MRI in the assessment of response of rectal cancer to neoadjuvant chemoradiotherapy: A comparison of morphological, volumetric and functional MRI parameters.
Hötker AM; Tarlinton L; Mazaheri Y; Woo KM; Gönen M; Saltz LB; Goodman KA; Garcia-Aguilar J; Gollub MJ
Eur Radiol; 2016 Dec; 26(12):4303-4312. PubMed ID: 26945761
[TBL] [Abstract][Full Text] [Related]
15. Perfusion-sensitive parameters of intravoxel incoherent motion MRI in rectal cancer: evaluation of reproducibility and correlation with dynamic contrast-enhanced MRI.
Yang X; Xiao X; Lu B; Chen Y; Wen Z; Yu S
Acta Radiol; 2019 May; 60(5):569-577. PubMed ID: 30114928
[TBL] [Abstract][Full Text] [Related]
16. Correlation of dynamic contrast-enhanced MRI perfusion parameters with angiogenesis and biologic aggressiveness of rectal cancer: Preliminary results.
Yeo DM; Oh SN; Jung CK; Lee MA; Oh ST; Rha SE; Jung SE; Byun JY; Gall P; Son Y
J Magn Reson Imaging; 2015 Feb; 41(2):474-80. PubMed ID: 24375840
[TBL] [Abstract][Full Text] [Related]
17. Correlation of standard diffusion-weighted imaging and diffusion kurtosis imaging with distant metastases of rectal carcinoma.
Yu J; Huang DY; Li Y; Dai X; Shi HB
J Magn Reson Imaging; 2016 Jul; 44(1):221-9. PubMed ID: 26715111
[TBL] [Abstract][Full Text] [Related]
18. Rectal cancer: dynamic contrast-enhanced MRI correlates with lymph node status and epidermal growth factor receptor expression.
Lollert A; Junginger T; Schimanski CC; Biesterfeld S; Gockel I; Düber C; Oberholzer K
J Magn Reson Imaging; 2014 Jun; 39(6):1436-42. PubMed ID: 24127411
[TBL] [Abstract][Full Text] [Related]
19. [Diagnostic value of quantitative pharmacokinetic parameters and relative quantitative pharmacokinetic parameters in breast lesions with dynamic contrast-enhanced MRI].
Sun TT; Liu WH; Zhang YQ; Li LH; Wang R; Ye YY
Zhonghua Yi Xue Za Zhi; 2017 Aug; 97(29):2266-2270. PubMed ID: 28780840
[No Abstract] [Full Text] [Related]
20. Added value of DCER-features to clinicopathologic model for predicting metachronous metastases in rectal cancer patients.
Dai J; Wang KX; Wu LY; Bai XH; Shi HY; Xu Q; Yu J
Abdom Radiol (NY); 2024 May; 49(5):1341-1350. PubMed ID: 38478038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
